Protected 4-hydroxycyclopentenones (4-HCPs) constitute an important class of intermediates in chemical synthesis. A route to this class of compound has been developed. Key steps include Noyori reduction (which establishes the stereochemistry of the product), ring-closing metathesis, and simple functional group conversions to provide a set of substituted 4-HCPs in either enantiomeric form.
the best-known examples of enzymes in organic synthesis (Figure 2) . 28, 29 The key step is the stereoselective hydrolysis of an enantiotopic acetate ester, 24 which affords an intermediate that is converted to TBS-protected enone (R)-1. [30] [31] [32] This route can be adapted to the synthesis of the S-configured series by modifying the protection/deprotection steps. 33 Having used existing methods for procuring 1 as a starting material 5 and contemplating further such applications, we sought to develop an alternative enantioselective synthesis of these compounds. We specifically hoped to create a convenient route that would allow ready and equal access to either enantiomer. In seeking to develop such a route, we noticed that the simple step of formally inverting one of the alcohol stereocenters in cis-1,2-dihydroxycyclopen-4-ene changes the timing and nature of the stereochemical issues to be considered ( Figure 3 ). In the enzymatic route, it is necessary to carry out two stereocontrolled steps: (1) the synthesis of the meso diacetate (i.e., only cis and not trans, generally accomplished from cyclopentadiene by 1 O 2 chemistry or by epoxidation followed by acetolysis of a derived π-allyl species 34 ) and (2) the enzyme-controlled enantioselective hydrolysis (Figure 3a) . 24 In contrast, the corresponding trans-diol would no longer have planar symmetry but instead be a chiral, C 2 -symmetric molecule (Figure 3b ). Thus, it would no longer be necessary to differentiate the two identical alcohol groups in future steps. Moreover, we felt that it would be possible to readily prepare this diol using the known asymmetric conversion of diketone 2 to 4, [35] [36] [37] [38] followed by ring-closing metathesis (RCM; Scheme 1 below). Thus, only a single stereoselective reaction would be required in the entire synthesis.
To make this happen, commerically available 1,5-dichloro-2,4-pentanedione 2 (also readily made from acetylacetone 35 ) was reduced as reported by Rychnovsky and coworkers to afford (R,R)-3 in 40% yield and ca. 97% enantioselectivity (es; Scheme 1). 36, 37 Following Hanson, treatment of diol 3 with the Corey-Chaykovsky reagent 39 gave diene diol 4 in 95% yield. 38 Various RCM conditions were tried, with the best results being obtained using Grubbs II 40 catalyst, which provided the cyclized product in 68% yield. In this way, diol 5 could be obtained in multigram amounts (enantiopure 5 is also available via enzymatic resolution 41 ). We were somewhat surprised to find that it was difficult to selectively carry out the monoprotection of 5 to afford ethers like 6. Although the initial silylation of 5 could be easily accomplished, the monoprotected material seemed to more readily undergo a second reaction with silylating reagent, complicating the route by introducing an inconvenient separation step.
In contrast, the monoprotection of diol 4 proceeded smoothly to provide a set of alcohols (R,R)-7 in moderate to excellent yields (Scheme 2). For example, TIPS-protected (R,R)-7a was obtained in 95% yield from diol 4 using n-BuLi and TIPSCl at −78 °C. As 4-HCPs appear in different protected guises in synthetic efforts, we prepared TBS-, acyl-and pmethoxybenzyl-protected versions as shown. Here, monoprotected diol (R,R)-7 was cyclized via RCM using Grubbs I catalyst 42 to obtain the four examples of (R,R)-6 shown in 88-92% yields. Finally, oxidation of (R,R)-6 with pyridinium chlorochromate provided the targeted O-protected-4-hydroxy-2-cyclopentenones (R)-1a-d in high enantioselectivities. We routinely prepare compound 6 in ca. 5-7 g quantities. This route can be modified for the synthesis of (S)-1 by simply using (R)-BINAP in the hydrogenation step (Scheme 3). Besides no longer requiring different schemes for preparing the two enantiomers, the present route proceeds in acceptable overall yields from commercially available starting materials (26-32%) and compares favorably in number of steps compared to other methods (5 steps from 2 to either (R)-or (S)-1 as opposed to 9 steps for the synthesis shown in Scheme 1a).
Another useful 4-HCP is the α-iodo derivative of enone 1a, which has found applications in the synthesis of prostaglandins and other natural products (for leading examples, see Roche and Aitken 1 ). Thus, we transformed both (R)-and (S)-1a into iodides 8 as shown in Scheme 4.
Just as 4-HCPs have been broadly employed in synthesis, 2-20 the reduced alcohol precursor introduced herein should be of comparable utility. We close by providing a few examples of this potential in Scheme 5. Thus, epoxidation of allylic alcohol 6a provided 9 exclusively in 66% yield (likely due to a reinforcing combination of Henbest-like delivery of peracid 43 and avoidance of the large OTIPS group). Epoxide opening occurred regioselectively with sodium azide to provide the highly substituted cyclopentane 10 in 69% yield. The stereoand regiochemistry of the product 10 was confirmed by 2D NMR analysis of the corresponding diacetylated compound (see Supporting Information). In addition, aminosubstituted cyclopentane derivatives 12, 13, and 14 were made using simple displacement chemistry.
In summary, we have demonstrated a convenient synthesis of 4-HCPs, an important class of privileged building blocks for organic synthesis. The route is scalable for laboratory usage and provides access to multiple analogs in either enantiomeric series of 4-HCPs using the identical route (save choice of catalyst).
Experimental Section General Methods
All reactions were carried out in oven-or flame-dried glassware under argon atmosphere using standard gas-tight syringes, cannulas, and septa. Et 2 O, THF and DCM were purified by passage through neutral alumina columns using a commercial solvent purification system. All chemicals were used as received from commercial source without further purification. Flash chromatography was either carried out on a standard grade silica gel (40-63 mm particle size, 230-400 mesh) with compressed nitrogen as a source of positive pressure or on an automated purification system using silica flash column. Infrared (IR) spectra were acquired as thin films. All nuclear magnetic resonance spectra ( 1 H, 13 C, COSY and 1D NOE) were recorded in deutrated chloroform on a 400 MHz instrument with a dual carbon/proton cryoprobe. Chemical shifts are reported in parts per million (ppm) and are referenced to the centerline of the solvent (d 7.26 ppm for 1 H NMR and 77.23 ppm for 13 C NMR). High-resolution mass spectra (HRMS) were recorded with a time-of-flight mass spectrometer and an electrospray (ESI) or atmospheric pressure chemical ionization (APCI) ion source. Observed optical rotations were measured at 589 nm. The er values of compounds 1a-c and compound 8 were determined by gas chromatography using a 5975CVL MSD triple-axis detector. The er value of the compound 1d was determined by chiral HPLC on an IC column with a 996 UV-detector.
Known compounds
The following compounds were prepared as previously described: 2, 1 (R,R)-3 and its S,Senantiomer, 35, 36 (R,R)-4 and its S,S-enantiomer. 37 
(1R,3R)-Cyclopent-4-ene-1,3-diol (5)
A solution of diol 4 (500 mg, 3.91 mmol) in DCM (78.2 mL) and methanol (78.2 mL) was purged with argon for 5 min and 5 mol% of Grubbs II catalyst (166 mg) was added to it. The reaction mixture was stirred at rt for 6 h and was quenched with DMSO (1 mL). The reaction mixture was stirred under air for 5 min and concentrated. The crude product was purified by silica gel chromatography (100% EtOAc) to afford the product as colorless oil (266 mg, 68%). R f = 0.20 (100% EtOAc); IR (neat) 3420 cm −1 ; 1 H NMR (400 MHz, CDCl 3 ) δ 6.05-6.01 (m, 2H), 5.07 (t, J = 4.8 Hz, 2H), 2.10 (t, J = 5.0 Hz, 2H), 1.56 (br s, 2H); 13 
(3R,5R)-5-((Triisopropylsilyl)oxy)hepta-1,6-dien-3-ol (7a)
To a stirred solution of (R,R)-4 (2.7 g, 21.1 mmol) in THF (200 mL) at −78 °C, was added n-BuLi (8.4 mL, 2.5 M in hexanes, 21.1 mmol) dropwise. The solution was allowed to stir for 20 min at −78 °C followed by the slow addition of TIPSCl (4.9 mL, 21.1 mmol). After 2 h, the reaction was allowed to slowly warm to rt overnight and was quenched with saturated aq NH 4 Cl (100 mL). The phases were separated the aq layer was washed with EtOAc (3 × 100 mL). The combined organic layer was washed with water (100 mL), brine, and dried (Na 2 SO 4 ), filtered, and concentrated. The crude extract was purified by silica gel chromatography (10% EtOAc/hexanes) to afford the product as yellow oil (5.4 g, 96% 
(3R,5R)-5-((tert-Butyldimethylsilyl)oxy)hepta-1,6-dien-3-ol (7b)
To a stirred solution of (R,R)-4 (150 mg, 1.17 mmol) and tertbutyldimethylsilyltrifluoromethane sulfonate (1.17 mmol, 0.269 mL) in THF (20 mL) at −78°C , 2,6-lutidine (1.36 mL, 11.7 mmol) was added dropwise via syringe. The solution was allowed to stir for 2 h at −78 °C. The reaction was quenched with saturated aq NH 4 Cl (20 mL) and extracted with ethyl acetate (3 × 30 mL). The combined organic phase was washed with brine, dried (Na 2 SO 4 ), filtered, and concentrated. The crude product was purified by silica gel chromatography (10% EtOAc/hexanes) to afford the desired product as colorless oil (260 mg, 92%). 
(3R,5R)-5-Hydroxyhepta-1,6-dien-3-yl acetate (7c)
To a stirred solution of (R,R)-4 (200 mg, 1.56 mmol) in acetonitrile (15 mL), triethyl orthoacetate (0.43 mL, 2.34 mmol) and p-toluenesulfonic acid (20 mg) were added. The reaction mixture was stirred at rt for 1 h and a mixture of hydrochloric acid in methanol (0.2 mL HCl in 1 mL MeOH) was added to it. The stirring was continued for another 3 h at rt. The reaction was quenched with saturated aq NaHCO 3 solution (10 mL) and was extracted with ethyl acetate (20 mL × 3). The combined organic layer was washed with brine, dried (Na 2 SO 4 ) and concentrated. Purification via flash column chromatography provided the desired product as colorless oil (213 mg, 82% 
General procedure for the synthesis of compounds 6a-d
A solution of starting diene (7a-7d) in DCM (0.02 M) was purged with argon for 5 min and Grubbs-I catalyst (3 mol%) was added to it under argon. The reaction mixture was stirred for 1 h at 50 °C and quenched with DMSO (1 mL). The solution was stirred under air for 5 min and concentrated. The solvent was evaporated and the crude reaction mixture was purified by silica gel flash column chromatography to obtain the product (6a-6d).
(1R,4R)-4-((Triisopropylsilyl)oxy)cyclopent-2-enol (6a)
Following the general procedure above, diene 7a (5.00 g, 17.6 mmol) provided cyclopentenol 6a (4.14 g, 92%) as a colorless oil. R f = 0. 41 
(1R,4R)-4-((tert-Butyldimethylsilyl)oxy)cyclopent-2-enol (6b)
Following the general procedure above, diene 7b (200 mg, 17.6 mmol) provided cyclopentenol 6b (156 mg, 88%) as a colorless oil. CDCl 3 ) δ 6.12-6.06 (m, 1H), 6.01-5.95 (m, 1H), 5.81-5.74 (m, 1H) 
General procedure for the synthesis of compounds (1a-d)
To a stirred solution of starting cyclopentenol (6a-6d) in DCM (0.1 M) was added pyridinium chlorochromate (1.5 eq.) at 0 °C. The reaction mixture was stirred at rt for 6 h followed by filtration over Celite. The Celite bed was washed with diethyl ether. The combined filtrate was concentrated, and purified by silica gel flash column chromatography to afford the desired enone (1a-1d).
(R)-4-((Triisopropylsilyl)oxy)cyclopent-2-enone (1a)
Following above general procedure cyclopentenol 6a (2.00 g, 7.81 mmol) provided cyclopentenone 1a (1.86 g, 94%) as a colorless oil. 
(R)-2-Iodo-4-((triisopropylsilyl)oxy)cyclopent-2-enone (8)
To a stirred solution of I 2 (10.7 g, 42 mmol) in Et 2 O (250 mL) was added pyiridine (2.1 mL, 25 mmol) followed by dropwise addition of (R)-4-((triisopropylsilyl)oxy)cyclopent-2-enone (8.9 g, 35 mmol) at rt. The reaction flask was completely covered with aluminum foil. After 24 h, the reaction was quenched with aq Na 2 S 2 O 3 (50 mL). The organic layer was washed with brine, dried (Na 2 SO 4 ), filtered and concentrated. The resulting oil was purified using silica gel chromatography (10% Et 2 O in hexanes) to afford the product as colorless oil (11 g, 85%) . To a solution of (1R,4R)-4-((triisopropylsilyl)oxy)cyclopent-2-enol (500 mg, 1.95 mmol) in DCM (20 mL) m-CPBA (657 mg, 2.93 mmol) was added at 0 °C and the reaction mixture was stirred at rt for 28 h. The reaction mixture was quenched with saturated aq Na 2 S 2 O 3 (20 mL) and extracted with DCM (3 × 50 mL). The combined organic layer was washed with saturated aq NaHCO 3 , brine and dried (Na 2 SO 4 ). Evaporation of the solvent followed by flash column chromatography (silica gel, 10% EtOAc/hexanes) gave the desired product as colorless oil (350 mg, 66%). , 1H), 1.12-0.94 (m, 21H) ; 13 show COSY correlation with H2 that confirms the regiochemistry of azide. Further existence of 1D NOE correlation of H1 with H3 and H2 with H4 confirms the stereochemistry of the compound 11, hence confirms the structure of 10 retrospectively.
2-((1S,4R)-4-((Triisopropylsilyl)oxy)cyclopent-2-en-1-yl)isoindoline-1,3-dione (11)
To a solution of (1R,4R)-4-((triisopropylsilyl)oxy)cyclopent-2-enol (300 mg, 1.17 mmol), phthaliimide (344 mg, 2.34 mmol) and triphenylphosphine (614 mg, 2.34 mmol) in benzene (10 mL) diethyldiazocarboxylate (0.36 mL, 2.34 mmol) was added dropwise at rt and the reaction mixture was stirred at rt for 24 h. The reaction mixture was quenched with water (10 mL) and was extracted with diethylether (3 × 30 mL). The combined organic layer was washed with brine, dried (Na 2 SO 4 ), filtered and concentrated. Flash column chromatography of the crude provided the desired product as viscous oil (319 mg, 68%). Representative approaches to (R)-1: (a) from tartaric acid, 21, 22 (b) asymmetric epoxide opening, 24 (c) the Noyori reduction, 25 and (d) or enzymatic hydrolysis. 28, [30] [31] [32] 33 Stereochemical issues encountered en route to (a) a chiral cis acetoxy alcohol and (b) a chiral trans diol.
Scheme 1.
Synthesis of C 2 -symmetric diol 5 and initial protection attempts.
